European Auto Surge
Discover a carefully selected group of automotive stocks positioned to benefit from Europe's surprisingly strong vehicle demand. Professional analysts have curated these companies from across the auto value chain to give you exposure to this regional growth story.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Stellantis NV
STLA
Current price
$9.94
As a major European automaker with brands like Peugeot, Fiat, and Opel, Stellantis is a direct beneficiary of strong consumer demand across the contin...
As a major European automaker with brands like Peugeot, Fiat, and Opel, Stellantis is a direct beneficiary of strong consumer demand across the continent.
Autoliv, Inc.
ALV
Current price
$119.84
As a leading supplier of automotive safety systems with significant operations in Europe, Autoliv's sales are directly tied to increased vehicle produ...
As a leading supplier of automotive safety systems with significant operations in Europe, Autoliv's sales are directly tied to increased vehicle production by European manufacturers.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
BMW's strong European sales signal broader regional strength in the auto sector, despite global headwinds. This theme captures companies benefiting from both traditional vehicle demand and the accelerating transition to electric vehicles across Europe, offering a timely opportunity based on actual sales data.
What You Need to Know
This group includes companies across the entire automotive ecosystem, from major manufacturers to parts suppliers and retailers. Many have significant European operations but vary in size, specialization, and global reach, providing diverse exposure to this regional trend.
Why These Stocks
These companies were strategically selected to capture different aspects of Europe's auto market strength. The list includes established European automakers, EV specialists expanding into Europe, critical component suppliers, and retailers who all stand to benefit from increased production and sales volumes.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+39.68%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 39.68% over the next year.
Stocks Rated Buy by Analysts
12 of 16 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 7.6% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
Rising European Tide
BMW's European sales jumped 10.1% despite global headwinds, suggesting the entire European auto sector could be undervalued. This upward trend might catch many investors by surprise.
The EV Connection
Europe's strong auto market includes growing demand for electric vehicles. This group gives you exposure to both traditional car leaders and the companies powering the EV revolution.
Beyond the Manufacturers
The smartest investors know strong car sales boost the entire ecosystem. This group includes component makers, electronics specialists, and retailers who often see bigger percentage gains than the major automakers themselves.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.